• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
layoffs cuts workforce reduction chairs boxes fired
Biotech

Biopharma layoffs maintain slowdown in Q1

Have we passed the peak of biotech layoffs? It’s too early to say for certain—but an intriguing story is playing out in the figures.
James Waldron Apr 1, 2026 8:42am
US currency next to a ruler pen and calculator

Top 10 pharma R&D budgets of 2025

Mar 30, 2026 3:00am
Fierce Biotech43png

Scaling Radioligand Therapy: Expanding the Impact of Theranostics

Brought to you by Curium
concept of two individuals in a dispute

In deal fraud dispute with Novo, KBP looks to revive heart drug

Apr 1, 2026 2:30am
whale jumping out of water
Favicon Fierce Pharma

FDA delays decision on Orca Bio’s cell therapy for blood cancers

Apr 1, 2026 8:00am
closed shuttered shut down closed
Favicon Fierce Pharma

Iterum initiates wind-down after failure to offload antibiotic

Mar 31, 2026 2:06pm
More News

After FDA refusal, IO Biotech surrenders to bankruptcy

Mar 31, 2026 10:17am

Ambrosia scores $100M series B to advance next-gen oral GLP-1

Mar 31, 2026 10:02am

Fierce Biotech Layoff Tracker 2026: Lipella, IO, Takeda & more

Mar 31, 2026 10:00am

BMS links up with Faro to use AI to improve trial protocols

Mar 31, 2026 9:00am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings